Skip to main content
OpenTrials
Completed

NCT Number: NCT02702024

The Effectiveness of Double Incision Technique in Uterus Preserving Surgery for Placenta Percreta

Placenta percreta is a life-threatening condition that patients are under risk of massive bleeding. It readily necessitates very complicated surgery even leads to mortality. Cesarean hysterectomy is the procedure that is acknowledged worldwide, however, recent studies discussing conservative treatment with segmental resections were published. Fetal extraction and segmental resection could be performed from same (single uterine incision) or two different (double uterine incision) incisions. In this study, the investigators aimed to evaluate the effectiveness and the results of double uterine incision.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–45 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Intraoperatively and pathologically confirmed diagnosis of placenta percreta

Exclusion criteria

-

Treatment and study plan

Double uterine incision technique in uterus preserving surgery for placenta percreta

Procedure

Primary outcomes

  1. The success of segmental resection (Uterus preserving surgery)

    Time frame: Postoperative one month

    No need for hysterectomy due to massive hemorrhage or any other reason in postoperative one month

Sponsors and collaborators

Lead sponsor

Kanuni Sultan Suleyman Training and Research Hospital

Other

Registry information

Important dates

Study start
2014
Primary completion
2016
First posted
Mar 8, 2016
Registry last updated
Mar 8, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.